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Introduction
Either as single treatment or in combination with stereotactic radiation therapy and microneurosurgery, endovascular embolization can be an effective treatment for cerebral arteriovenous malformations (AVMs). 1 One of the most frequently used materials for AVM embolization is Onyx (Medtronic Neurovascular, Irvine, CA, USA), a liquid embolic agent (LEA), consisting of ethylene vinyl alcohol copolymer (EVOH), dimethyl-sulfoxide and tantalum powder, the latter causing radiopacity. 2 A frequently reported drawback of Onyx is the production of artifacts in diagnostic imaging caused by the inherent tantalum in terms of streak artifacts in conventional and cone-beam computed tomography (CT) and, to a lesser extent, in terms of susceptibility artifacts in magnetic resonance imaging (MRI). [3] [4] [5] [6] [7] These artifacts can be highly relevant in daily clinical practice as they can limit the diagnosis of peri-and postoperative complications and of residual or recurrent disease. 3, 4 Furthermore, the planning of subsequent stereotactic radiation therapy can be impeded and the dose and dose distribution of the radiation can be altered. 5, 7, 8 New embolic agents are being introduced in order to enlarge the armamentarium of materials for endovascular embolization and to ultimately improve the outcome of endovascular treatment of AVMs.
covalently bound iodine for radiopacity instead of tantalum. Several clinical and preclinical studies demonstrated that PHIL is suitable for endovascular embolization of AVMs and arteriovenous fistulas (AVFs) and, beyond that, described a low degree of artifacts in CT imaging. [11] [12] [13] [14] [15] [16] This low degree of artifacts was mentioned in all of these studies. However, these artifacts were neither assessed qualitatively or quantitatively nor compared to another LEA in any clinical or preclinical study.
The aim of the present study is the assessment of artifacts in conventional CT, cone-beam CT and MRI, caused by Onyx and PHIL, in an in vivo embolization model.
Materials and methods

Animal procedure
State Animal Care and Ethics Committee approval was obtained. All experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals.
Ten landrace pigs with a weight of 38-42 kg were used. Anesthesia and sacrifice (two hours after intervention) were performed as described previously. 17 
Embolization
The rete mirabile (RM) is a fine vascular network, located bilaterally at the cranial base of pigs, consisting of vessels that are similar to human arterioles and has been used as an endovascular embolization model by a number of investigators. 9, 11, [18] [19] [20] Embolization of the RM was performed using either Onyx or PHIL. 21 Of the different concentrations that are available for these LEAs, the least viscous concentrations (Onyx 18 and PHIL 25%) were used to achieve effective filling of the RM. The required volume of LEA was assessed. The embolization technique, characteristics and results were published previously and were not the focus of this study; they were accordingly not evaluated in this work. 21 
Imaging
All examinations (conventional CT, cone-beam CT and MRI) were performed with standard settings according to clinical practice.
Conventional CT imaging was performed with a 64-slice multidetector scanner (Somatom Definition Flash; Siemens Healthineers, Erlangen, Germany) applying an automated dose optimization software (CareDose and CarekV; Siemens) with a dose setting for CT dose index vol of 6.0 mGy and a collimation of 64 Â 0.6 mm. CT images were reconstructed in the axial plane by applying an iterative reconstruction software (Admire 3/5; Siemens; reconstruction kernel: I30-30) with a slice thickness of 3 mm and an overlap of 2 mm.
Cone-beam CT was obtained on a monoplanar angiography system (Artis zee; Siemens) with the following parameters: six-second rotational acquisition generating 396 projections with an angular step of 0.5 degrees for a total coverage of 200 degrees with a pulse length of 5 ms and a dose per frame of 0.36 mGy. Images were reconstructed in the axial plane with a slice thickness of 1 mm.
MRI examinations were performed using a 1.5T MRI system (MAGNETOM Aera; Siemens) with a 12-channel-head-matrix coil. A three-dimensional (3D 
Artifacts
Qualitative image analysis. All reconstructed images were reviewed on a picture archiving and communication system work station (CENTRICITY PACS 4.0; GE Healthcare, Barrington, IL, USA) by three readers (D.F.V., C.M.S. and M.A.M. with 5, 12, and 14 years of experience in diagnostic imaging, respectively), blinded to the type of LEA. All analyses were performed on axial reconstructions. For each modality and each animal, all readings were performed on seven images: the image with the most severe artifacts and the three images cranial and caudal to this image, respectively. The observers were allowed to adjust the window. The artifact severity and the feasibility of evaluating the adjacent brain tissue were graded using a five-point Likert scale: 22 (1) major artifacts, no depiction of anatomical structures; (2) marked artifacts, no depiction of surrounding tissue and considerably impaired image quality of distant tissue; (3) moderate artifacts, nondiagnostic in the surrounding tissue but fair diagnostic image quality of distant tissue; (4) minor artifacts with good image quality; and (5) no artifacts, full diagnostic image.
Quantitative image analysis. For objective measurement of the degree of artifacts, specific regions of interest (ROIs) were positioned and analyzed on the axial reconstruction with the most severe artifacts or, in the absence of explicit artifacts, on the reconstruction with the RM being most markedly filled, and on an axial reconstruction 20 mm cranial to the RM without any artifacts. 22 Accordingly, as illustrated in Figure 1 , four different ROIs were defined: ROI 1 : region with the most severe artifacts; ROI 2 : region near the RM, defined as 30 mm (referring to the center of the ROI) dorsal to the clivus, on the reconstruction with the most severe artifacts; ROI 3 : region distal to the RM, defined as 45 mm dorsal to the clivus, on the reconstruction with the most severe artifacts; ROI 4 (control ROI): region cranial to the RM (normal brain tissue), not affected by artifacts. For precise assessment of the region with the most severe artifacts, the size of this ROI (ROI 1 ) was set to 20 mm 2 , while the size of the remaining ROIs was set to 60 mm 2 . As a marker for the severity of the artifacts, the difference between the mean Hounsfield units (HU) in ROI 1-3 (images potentially affected by artifacts) and the mean HU in ROI 4 (image not affected by artifacts) was calculated, and defined as ÁMean-ROI 1, ÁMean-ROI 2 and ÁMean-ROI 3 , respectively. Since streak artifacts usually consist of very ''bright'' (high HU) and very ''dark'' (low HU) areas, mean HU can be normal despite there being severe artifacts. Therefore, the standard deviation (SD) of ROI [1] [2] [3] [4] was assessed, herein after referred to as SD-ROI 1, SD-ROI 2 , SD-ROI 3 and SD-ROI 4 . Accordingly, ÁROI 1-3 and SD-ROI [1] [2] [3] [4] were compared between Onyx and PHIL for conventional CT and cone-beam CT. Since there were no artifacts in MRI in the qualitative image analysis, no quantitative image analysis of the MRI images was performed.
Statistics
Prism software (version 7.02; GraphPad, La Jolla, CA, USA) was used for data analysis. Quantitative data are presented as medians (lower quartile; upper quartile). For the qualitative image analysis, interreader agreement was assessed by using a weighted k with a 95% confidence interval. 23 The k values were interpreted as follows: 0.20, poor agreement; 0.21-0.40, fair agreement; 0.41-0.60, moderate agreement; 0.61-0.80, good agreement; and 0.81-1.00, very good agreement. 24 To evaluate statistical differences between the two study groups, the Mann-Whitney test was performed. P values < 0.05 were considered statistically significant.
Results
All embolization procedures were performed as planned. Examples of postinterventional conventional CT and cone-beam CT are demonstrated in Figure 2 . Examples of postinterventional MRI are demonstrated in Figure 3 . The volume of required LEA was not significantly different (p ¼ 0.286) between Onyx (0.6 ml (0.45 ml; 0.95 ml)) and PHIL (0.5 ml (0.25 ml; 0.5 ml)).
The results of the qualitative image analysis are illustrated in Figure 4 . There was very good agreement (90% concordance, k ¼ 0.907 (range: 0.697-1.000)) for conventional CT and good agreement (70% concordance, k ¼ 0.726 (range: 0.514-0.939)) for cone-beam CT in the scoring of the artifacts in the qualitative image analysis. In conventional CT, artifact severity was graded higher (p ¼ 0.008) for Onyx (2 (2; 3), all readers) than for PHIL (5 (5; 5), all readers). Also in cone-beam CT, artifacts were graded as more intense (p ¼ 0.008) for Onyx (1 (1; 2), reader 1; 2 (1; 2), reader 2; 2 (1; 2), reader 3) when compared with PHIL (3 (3; 3), reader 1; 3 (3; 4), reader 2; 3 (3; 4), reader 3). In MRI, in T1-and T2-weighted sequences for both LEAs all readers did not detect any artifacts (a score of 5 for all images). In SWI, the LEA cast was not definable because of artifacts caused by the skull base.
The results of the quantitative image analysis are summarized in Table 1 and illustrated in Figure 4 . The difference between the mean HU in the reconstruction with the most severe artifacts and the reconstruction without any apparent artifacts (ÁMean-ROI 1-3 ) was significantly higher for Onyx for all ROIs on conventional CT and for the ROI in the region with the most severe artifacts (ÁMean-ROI 1 ) only on conebeam CT. The SD of the ROIs was significantly higher for Onyx for ROI 1 and ROI 2 on conventional CT and for ROI 1 , ROI 2 and ROI 3 on cone-beam CT.
Artifacts were more pronounced in cone-beam CT than in conventional CT; however, no direct comparison of these two modalities with respect to artifact severity was performed.
Discussion
A variety of embolic agents is currently available for the endovascular treatment of vascular pathologies, each with specific advantages and disadvantages with regard to the particular pathology to be treated (e.g. different requirements for high-flow or low-flow lesions, AVMs or AVFs and with regard to caliber and length of feeding and draining vessels). 25 The treatment success of cerebral AVMs has considerably improved in the last decade, which is, among other factors, often attributed to the introduction of the EVOH-based LEA Onyx. 2, [25] [26] [27] Despite the potential advantages of Onyx over other LEAs, there are still several shortcomings reported by interventionalists, one of these being the production of imaging artifacts, especially in periand postprocedural CT imaging. 3, 4 PHIL, a LEA that was introduced to the market in 2015, is based on a biocompatible copolymer and uses covalently bound iodine for radiopacity, instead of tantalum, the latter being admixed to Onyx. As initially indicated, several studies demonstrated the feasibility, safety, efficacy and, albeit with only short observation times, the biocompatibility of PHIL, although the number of cases (experiments and patients) was small in these studies. [11] [12] [13] [14] [15] [16] All of these studies mentioned the low degree of artifacts caused by PHIL, however, without qualitatively or quantitatively measuring these artifacts and without any direct comparison to other LEAs. In this experimental in vivo study we demonstrated that PHIL produces fewer artifacts than Onyx in conventional and cone-beam CT, evaluated by applying subjective image analysis, performed by three experienced radiologists, and quantitative HU measurements. Quantitatively, the observed streak artifacts were represented by low or high HU values and by a high spread of the HU in specific ROIs in proximity to the LEA cast.
The underlying reason for the artifact production by Onyx and PHIL in CT imaging is the high absorption of photons by the admixed high atomic number materials tantalum (anatomic number of 73) for Onyx and iodine (atomic number of 53) for PHIL, resulting in beam hardening, scatter and noise, which are visible as dark and bright streaks in the reconstructed CT image. 4, 8, 28 The higher degree of artifact production by Onyx can accordingly be explained by the higher atomic number of tantalum.
Both LEAs did not produce any apparent artifacts in MRI. This finding is in line with the literature. Only a few studies have described a limited diagnostic evaluation due to artifacts of Onyx in MRI, with the most pronounced artifact in diffusion-weighted sequences, while most studies observed no or only negligible artifacts caused by Onyx. 3, 4, 6, 7 For PHIL, to the best of our knowledge, the presence of MRI artifacts was not evaluated before.
Peri-and postinterventional procedure-related intracranial hemorrhage is one of the most feared complications of the treatment of cerebral AVMs, occurring in 0% to 12% of cases, with most series being concentrated between 6% and 9%. 2, 26, 29 In the case of suspected procedure-related hemorrhage, cone-beam CT (mainly peri-procedural) and conventional CT (mainly post-procedural) are the imaging modalities of choice. As initially indicated, after AVM embolization with Onyx, because of severe streak artifacts, the evaluation of the most relevant CT images, namely the images at the level of the embolized AVM, can be significantly restricted or even impossible. 3, 4, 7, 8 After endovascular embolization, angiography represents the gold-standard imaging modality for the evaluation of treatment success. 25 The aforementioned artifacts do not impair the diagnostic accuracy b) and (e)) and susceptibility-weighted ((c) and (f)) images; axial reconstructions. Note the absence of any apparent artifacts in T1-and T2-weighted images. Onyx was visible as hypointense material in T1-and T2-weighted sequences (white arrows). In the susceptibility-weighted sequences, the LEA cast was not definable because of artifacts caused by the osseous, partially pneumatized skull base. PHIL could not be identified in MRI. LEA: liquid embolic agent; MRI: magnetic resonance imaging; PHIL: precipitating hydrophobic injectable liquid. of angiography. However, if performing an angiography is not possible (e.g. because of refusal by the patient, advanced renal insufficiency or severe contrast agent allergy), MRI is the imaging modality of choice for the further evaluation of the AVM. 4, 6 In MRI, susceptibility artifacts caused by magnetic field inhomogeneities, induced by foreign implants, can impede the assessment of the AVM, such as AVM-related aneurysms, (residual) arterial blood flow within the nidus or within the draining veins or contrast enhancement of the nidus. 4, 6, 7 However, the findings of this experimental study suggest that the radiological evaluation of MRI images is not impeded by Onyx or PHIL.
Another important aspect for which imaging artifacts of LEAs can be relevant is postembolization stereotactic radiation therapy. Owing to the abovementioned artifacts in treatment-planning CT, delineation of the AVM nidus and accordingly of the target volume can be impeded and consequently cause errors in dose calculations, which need to be identified and resolved during treatment planning. 5, 7, 8 Furthermore, image distortion, induced by foreign materials such as Onyx, can influence the automated dose calculation of the treatment planning system, potentially leading to overor underdosing of the AVM. 5, 7, 8 Even though the lower degree of artifacts in CT imaging can be seen as an advantage of PHIL over Onyx, and preclinical and preliminary clinical studies demonstrated that PHIL can be an effective LEA, clinical studies with a sufficient number of patients and sufficient follow-up times are needed to define the value of PHIL for endovascular embolization of AVMs and AVFs.
There are some limitations in our study. First, the number of trials was small; however, the findings were consistent in the different analyses for the two embolic agents. Second, the assessment of artifacts near the RM is impeded because of its proximity to the skull base (absorbance of artifacts in the ventral direction and production of artifacts by the skull base). Third, even though the volume of required LEA was not significantly different, the higher volume of Onyx could have led to significantly more artifacts. Fourth, the transferability of an experimental in vivo study to clinical practice is generally limited.
Conclusion
In this experimental in vivo study, PHIL produced fewer artifacts than Onyx on conventional and conebeam CT, which could facilitate the diagnosis of peri-and postprocedural hemorrhage and subsequent stereotactic radiation therapy.
